相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prolyl oligopeptidase inhibition activates autophagy via protein phosphatase 2A
Reinis Svarcbahs et al.
PHARMACOLOGICAL RESEARCH (2020)
Prolyl endopeptidase gene disruption attenuates high fat diet-induced nonalcoholic fatty liver disease in mice by improving hepatic steatosis and inflammation
Dai-Xi Jiang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Extracellular prolyl oligopeptidase derived from activated microglia is a potential neuroprotection target
Teemu A. Natunen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2019)
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Zobair Younossi et al.
HEPATOLOGY (2019)
Triggering and resolution of inflammation in NASH
Susanne Schuster et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
A systematic review of p53 regulation of oxidative stress in skeletal muscle
Kaitlyn Beyfuss et al.
REDOX REPORT (2018)
Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From two hit theory to multiple hit model
Yan-Lan Fang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo
Reinis Svarcbahs et al.
SCIENTIFIC REPORTS (2018)
p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease
Zhibin Yan et al.
LIFE SCIENCES (2018)
Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances
Jennie Ka Ching Lau et al.
JOURNAL OF PATHOLOGY (2017)
The prolyl oligopeptidase inhibitor SUAM-14746 attenuates the proliferation of human breast cancer cell lines in vitro
Satoshi Tanaka et al.
BREAST CANCER (2017)
Animal Models of Nonalcoholic Fatty Liver Disease-A Starter's Guide
Mikhail A. Van Herck et al.
NUTRIENTS (2017)
Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis
Schohraya Spahis et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Deficiency of prolyl oligopeptidase in mice disturbs synaptic plasticity and reduces anxiety-like behaviour, body weight, and brain volume
Corinna Hoefling et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Elena Buzzetti et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
The antioxidant function of sestrins is mediated by promotion of autophagic degradation of Keap1 and Nrf2 activation and by inhibition of mTORC1
Sue Goo Rhee et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease
N. U. Ashraf et al.
FREE RADICAL RESEARCH (2015)
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
Robert J. Wong et al.
GASTROENTEROLOGY (2015)
Nonalcoholic Fatty Liver Disease A Systematic Review
Mary E. Rinella
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
The expression levels of prolyl oligopeptidase responds not only to neuroinflammation but also to systemic inflammation upon liver failure in rat models and cirrhotic patients
Jofre Tenorio-Laranga et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Adaptive Immune Responses Triggered by Oxidative Stress Contribute to Hepatic Inflammation in NASH
Salvatore Sutti et al.
HEPATOLOGY (2014)
Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers
Lana Dokleja et al.
NEUROSCIENCE LETTERS (2014)
Distribution of Prolyl Oligopeptidase in Human Peripheral Tissues and in Ovarian and Colorectal Tumors
Timo T. Myohanen et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshihisa Takahashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Prolyl oligopeptidase participates in cell cycle progression in a human neuroblastoma cell line
Minoru Sakaguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Prolyl endopeptidase is revealed following SILAC analysis to be a novel mediator of human microglial and THP-1 cell neurotoxicity
Andis Klegeris et al.
GLIA (2008)
Distribution of prolyl oligopeptidase in the mouse whole-body sections and peripheral tissues
Timo T. Myohanen et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2008)
A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation
Amit Gaggar et al.
JOURNAL OF IMMUNOLOGY (2008)
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
Fabio Marra et al.
TRENDS IN MOLECULAR MEDICINE (2008)
A prolyl oligopeptidase inhibitor, Z-Pro-Prolinal, inhibits glyceraldehyde-3-phosphate dehydrogenase translocation and production of reactive oxygen species in CV1-P cells exposed to 6-hydroxydopamine
Katja A. Puttonen et al.
TOXICOLOGY IN VITRO (2006)
Localization of the mRNA encoding prolyl endopeptidase in the rat brain and pituitary
G Bellemère et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
分享论文
